. Author manuscript; available in PMC: 2010 Oct 1.

Published in final edited form as: Pediatr Blood Cancer. 2009 Oct;53(4):629–634. doi: 10.1002/pbc.22125

Table I.

Demographics

	Age of onset	Gender	Age at initial evaluation	Age (yrs) at most recent evaluation	Disease variant		Clinical outcome
	Age of onset	Gender	Age at initial evaluation	Age (yrs) at most recent evaluation	At diagnosis	At follow up	Clinical outcome
1	6m	F	3y	24	UP	UP	Major regression
2	3m	M	11m	21	UP	Resolved	Complete regression
3	6m	M	3y	23^*	UP	Resolved	Complete regression
4	3m	F	3y	19	UP	UP	Major regression
5	2y	F	8y	26	UP	UP	Major regression
6	2y	M	5y	NF	UP	Unknown	Unknown
7	1m	M	2y	23^*	UP	Resolved	Complete regression
8	4d	M	1y	21	UP	Resolved	Complete regression
9	3m	M	3m	21	DCM	Resolved	Complete regression
10	1y	M	3y	17	UP	Resolved	Complete regression
11	birth	M	5m	18	DCM	DCM	Partial regression
12	6w	M	4y	24^*	UP	Resolved	Complete regression
13	2m	M	6m	20	UP	Resolved	Complete regression
14	birth	M	6m	20	UP	UP/ISM	Partial regression^†
15	3m	M	3y	18	UP	Resolved	Complete regression
16	4m	M	7m	NF	UP	Unknown	Unknown
17	birth	M	3y	19	UP	Resolved	Complete regression

d-days, w-weeks, m-months, y-years; UP-Urticaria Pigmentosa, NF-no follow up, DCM-Diffuse Cutaneous Mastocytosis, and ISM-Indolent Systemic Mastocytosis

Contacted by phone only

^†

Patient’s initial marrow re-read as diagnostic of indolent systemic mastocytosis